United States · FDA National Drug Code directory
oxybutynin chloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 16729-317_461437aa-cf86-2475-e063-6294a90afe5b
- Product NDC
- 16729-317
- Form
- TABLET, EXTENDED RELEASE
- Composition / generic term
- oxybutynin chloride
- Labeler
- Accord Healthcare, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20161214
- Source listing expiry
- 20261231
Source-listed ingredients
- OXYBUTYNIN CHLORIDE — 5 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (16729-317-01) · 16729-317-01
- 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (16729-317-16) · 16729-317-16
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →